申请人:GLAXO GROUP LIMITED
公开号:US20140249126A1
公开(公告)日:2014-09-04
The present invention relates to cephalosporin antibacterial compounds of Formula (I):
or
corresponding pharmaceutically acceptable salts thereof, corresponding pharmaceutical compositions, compound preparation and treatment methods for bacterial infections, especially those caused by gram-negative bacteria.
本发明涉及式(I)的头孢菌素抗菌化合物:或其相应的药学上可接受的盐,相应的制药组合物,化合物制备和治疗细菌感染的方法,特别是由革兰氏阴性菌引起的感染。